International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

被引：0

作者：

A Palumbo

O Sezer

R Kyle

J S Miguel

R Z Orlowski

P Moreau

R Niesvizky

G Morgan

R Comenzo

P Sonneveld

S Kumar

R Hajek

S Giralt

S Bringhen

K C Anderson

P G Richardson

M Cavo

F Davies

J Bladé

H Einsele

M A Dimopoulos

A Spencer

A Dispenzieri

T Reiman

K Shimizu

J H Lee

M Attal

M Boccadoro

M Mateos

W Chen

H Ludwig

D Joshua

J Chim

V Hungria

I Turesson

B G M Durie

S Lonial

机构：

[1] Azienda Ospedaliera S. Giovanni Battista,Divisione di Ematologia dell'Università di Torino

[2] Ospedale Molinette,Department of Hematology/Oncology

[3] Charité–Universitaetsmedizin Berlin,Division of Hematology

[4] Mayo Clinic,Department of Lymphoma/Myeloma

[5] Servicio de Hematología,Department of Clinical Hematology

[6] Hospital Universitario de Salamanca. CIC,Department of Hematology

[7] IBMCC (USAL-CSIC),Department of Internal Medicine

[8] The University of Texas MD Anderson Cancer Center,Department of Medical Oncology

[9] University Hospital,Department of Hematology

[10] Center for Lymphoma and Myeloma,Department of Clinical Therapeutics

[11] Weill Medical College of Cornell University,Department of Haematology

[12] Institute of Cancer Research,Department of Medicine

[13] Royal Marsden Hospital,Department of Internal Medicine

[14] Blood Bank and Stem Cell Processing Laboratory,Division of Hematology

[15] Tufts Medical Center,Oncology

[16] Erasmus MC,Department of Hematology

[17] University Hospital Brno,Department of Biostatistics

[18] Dana-Farber Cancer Institute,Department of Hematology

[19] Institute of Hematology and Medical Oncology,Department of Oncology

[20] Hospital Clinic,First Medical Department and Medical Oncology

[21] Universitätsklinik Würzburg,Department of Medicine

[22] Medizinische Klinik und Poliklinik II,Department of Hematology

[23] University of Athens School of Medicine,Department of Hematology/Medicine

[24] The Alfred Hospital,Department of Hematology

[25] Cross Cancer Institute,undefined

[26] Nagoya City Midori General Hospital,undefined

[27] Gachon University Gil Hospital,undefined

[28] Service d'Hématologie,undefined

[29] Hôpital Purpan,undefined

[30] Service d'Hématologie,undefined

[31] Hôpital Purpan,undefined

[32] Beijing Chaoyang Hospital,undefined

[33] Capital Medical University,undefined

[34] Beijing Chaoyang Hospital,undefined

[35] Capital Medical University,undefined

[36] Wilhelminenspital,undefined

[37] Institute of Hematology,undefined

[38] Royal Prince Alfred Hospital,undefined

[39] Bosch University of Sydney,undefined

[40] Queen Mary Hospital,undefined

[41] Clinica São Germano,undefined

[42] Malmö University Hospital,undefined

[43] Aptium Oncology Inc.,undefined

[44] Cedars-Sinai Outpatient Cancer Center at the Samuel Oschin Comprehensive Cancer Institute,undefined

[45] Emory University,undefined

来源：

Leukemia | 2009年 / 23卷

关键词：

myeloma; guidelines; treatment; chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

In 2005, the first guidelines were published on the management of patients with multiple myeloma (MM). An expert panel reviewed the currently available literature as the basis for a set of revised and updated consensus guidelines for the diagnosis and management of patients with MM who are not eligible for autologous stem cell transplantation. Here we present recommendations on the diagnosis, treatment of newly diagnosed non-transplant-eligible patients and the management of complications occurring during induction therapy among these patients. These guidelines will aid the physician in daily clinical practice and will ensure optimal care for patients with MM.

引用

页码：1716 / 1730

页数：14

共 50 条

[1] International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation
Palumbo, A.
Sezer, O.
Kyle, R.
Miguel, J. S.
Orlowski, R. Z.
Moreau, P.
Niesvizky, R.
Morgan, G.
Comenzo, R.
Sonneveld, P.
Kumar, S.
Hajek, R.
Giralt, S.
Bringhen, S.
Anderson, K. C.
Richardson, P. G.
Cavo, M.
Davies, F.
Blade, J.
Einsele, H.
Dimopoulos, M. A.
Spencer, A.
Dispenzieri, A.
Reiman, T.
Shimizu, K.
Lee, J. H.
Attal, M.
Boccadoro, M.
Mateos, M.
Chen, W.
Ludwig, H.
Joshua, D.
Chim, J.
Hungria, V.
Turesson, I.
Durie, B. G. M.
Lonial, S.
LEUKEMIA, 2009, 23 (10) : 1716 - 1730
[2] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
Gertz, Marie A.
Lacy, Martha Q.
Dispenzieri, Angela
Hayman, Suzanne R.
Kumar, Shaji K.
EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
[3] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
Lisenko, Katharina
Sauer, Sandra
Bruckner, Thomas
Egerer, Gerlinde
Goldschmidt, Hartmut
Hillengass, Jens
Schmier, Johann W.
Shah, Sofia
Witzens-Harig, Mathias
Ho, Anthony D.
Wuchter, Patrick
BMC CANCER, 2017, 17
[4] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
Katharina Lisenko
Sandra Sauer
Thomas Bruckner
Gerlinde Egerer
Hartmut Goldschmidt
Jens Hillengass
Johann W. Schmier
Sofia Shah
Mathias Witzens-Harig
Anthony D. Ho
Patrick Wuchter
BMC Cancer, 17
[5] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA WITH RENAL FAILURE
Pokrovskaya, O.
Mendeleeva, L.
Urnova, E.
Firsova, M.
Nareyko, M.
Kuzmina, L.
Rekhtina, I.
Tauson, I.
Varlamova, E.
Parovichnikova, E.
Savchenko, V.
BONE MARROW TRANSPLANTATION, 2014, 49 : S345 - S346
[6] Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma
Yohay, Stephanie
Oloyede, Temitope
Kim, Soyoung
Fang, Xi
Dhakal, Binod
Aijaz, Ayesha
Mohan, Meera
Narra, Ravi
Pasquini, Marcelo
D'Souza, Anita
Hamadani, Mehdi
Freeman, Ciara Louise
Akhtar, Othman Salim
BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2370 - 2375
[7] OUTCOMES OF FRAIL PATIENTS RECEIVING HIGH-DOSE CHEMOTHERAPY/AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
Yohay, Stephanie
Oloyede, Temitope
Dhakal, Binod
D'Souza, Anita
Aijaz, Ayesha
Mohan, Meera
Narra, Ravi
Pasquini, Marcelo
Hamadani, Mehdi
Freeman, Ciara Louise
Akhtar, Othman Salim
BONE MARROW TRANSPLANTATION, 2024, 59 : 517 - 517
[8] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency
Ballester, OF
Tummala, R
Janssen, WE
Fields, KK
Hiemenz, JW
Goldstein, SC
Perkins, JB
Sullivan, DM
Rosen, R
Sackstein, R
Zorsky, P
Saez, R
Elfenbein, GJ
BONE MARROW TRANSPLANTATION, 1997, 20 (08) : 653 - 656
[9] High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency
OF Ballester
R Tummala
WE Janssen
KK Fields
JW Hiemenz
SC Goldstein
JB Perkins
DM Sullivan
R Rosen
R Sackstein
P Zorsky
R Saez
GJ Elfenbein
Bone Marrow Transplantation, 1997, 20 : 653 - 656
[10] High-dose chemotherapy with autologous stem-cell support in multiple myeloma
Ruckser, R
Kier, P
Buxhofer, V
Kittl, E
Tatzreiter, G
Vedovelli, H
Zelenka, P
Hübl, G
Hinterberger, W
ACTA MEDICA AUSTRIACA, 2000, 27 : 40 - 42

← 1 2 3 4 5 →